130 related articles for article (PubMed ID: 13129566)
61. [Synthesis and antitumor activity of cinnamoyloxy phosphonate derivatives].
Yang JQ; Lei J; Li G; Wan XQ
Yao Xue Xue Bao; 2016 Mar; 51(3):420-4. PubMed ID: 29859023
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
[TBL] [Abstract][Full Text] [Related]
63. Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides.
Chibale K; Ojima I; Haupt H; Geng X; Pera P; Bernacki RJ
Bioorg Med Chem Lett; 2001 Sep; 11(18):2457-60. PubMed ID: 11549446
[TBL] [Abstract][Full Text] [Related]
64. Modulating paclitaxel bioavailability for targeting prostate cancer.
Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
[TBL] [Abstract][Full Text] [Related]
65. Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase.
Farr RA; Bey P; Sunkara PS; Lippert BJ
J Med Chem; 1989 Aug; 32(8):1879-85. PubMed ID: 2666666
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.
Llauger L; He H; Kim J; Aguirre J; Rosen N; Peters U; Davies P; Chiosis G
J Med Chem; 2005 Apr; 48(8):2892-905. PubMed ID: 15828828
[TBL] [Abstract][Full Text] [Related]
68. New synthetic inhibitors of microtubule depolymerization.
Klar U; Graf H; Schenk O; Röhr B; Schulz H
Bioorg Med Chem Lett; 1998 Jun; 8(11):1397-402. PubMed ID: 9871773
[TBL] [Abstract][Full Text] [Related]
69. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
[TBL] [Abstract][Full Text] [Related]
70. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
71. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
[TBL] [Abstract][Full Text] [Related]
72. Discovery of an L-alanine ester prodrug of the Hsp90 inhibitor, MPC-3100.
Kim SH; Tangallapally R; Kim IC; Trovato R; Parker D; Patton JS; Reeves L; Bradford C; Wettstein D; Baichwal V; Papac D; Bajji A; Carlson R; Yager KM
Bioorg Med Chem Lett; 2015 Nov; 25(22):5254-7. PubMed ID: 26483201
[TBL] [Abstract][Full Text] [Related]
73. Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl)cyclopent-2-ene-1-one.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Bioorg Med Chem; 2003 Mar; 11(6):1021-9. PubMed ID: 12614888
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and Evaluation of Millepachine Amino Acid Prodrugs With Enhanced Solubility as Antitumor Agents.
Wu Y; Cao D; Wang F; Ma L; Gao G; Chen L
Chem Biol Drug Des; 2015 Oct; 86(4):559-67. PubMed ID: 25643726
[TBL] [Abstract][Full Text] [Related]
75. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
76. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and evaluation of daunorubicin-paclitaxel dimers.
Kar AK; Braun PD; Wandless TJ
Bioorg Med Chem Lett; 2000 Feb; 10(3):261-4. PubMed ID: 10698449
[TBL] [Abstract][Full Text] [Related]
78. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis, and biological properties of highly potent epothilone B analogues.
Nicolaou KC; Sasmal PK; Rassias G; Reddy MV; Altmann KH; Wartmann M; O'Brate A; Giannakakou P
Angew Chem Int Ed Engl; 2003 Aug; 42(30):3515-20. PubMed ID: 12900969
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
